The hypomethylation of KRAS in BLCA, READ, and COAD is low compared to their normal counterparts, which matched the low level of KRAS in these tumor cohorts (Figure 3F,G, Supplementary Figure S1D). This evidence concerns the gene KRAS and bladder transitional cell carcinoma.